| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD4-Positive T-Lymphocytes | 111 | 2023 | 636 | 16.500 |
Why?
|
| Immunologic Memory | 69 | 2023 | 287 | 11.020 |
Why?
|
| Orthomyxoviridae Infections | 23 | 2020 | 71 | 4.540 |
Why?
|
| Influenza, Human | 18 | 2022 | 208 | 4.510 |
Why?
|
| Aging | 26 | 2020 | 743 | 4.090 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 43 | 2022 | 112 | 4.070 |
Why?
|
| Lymphocyte Activation | 85 | 2017 | 754 | 3.960 |
Why?
|
| T-Lymphocyte Subsets | 39 | 2023 | 245 | 3.930 |
Why?
|
| Interleukin-2 | 51 | 2023 | 166 | 3.810 |
Why?
|
| Influenza A virus | 19 | 2022 | 123 | 3.780 |
Why?
|
| Influenza Vaccines | 11 | 2022 | 98 | 3.740 |
Why?
|
| B-Lymphocytes | 54 | 2022 | 573 | 2.720 |
Why?
|
| T-Lymphocytes | 47 | 2022 | 1003 | 2.570 |
Why?
|
| Mice | 181 | 2023 | 10751 | 2.510 |
Why?
|
| Cytokines | 41 | 2020 | 926 | 2.430 |
Why?
|
| Animals | 212 | 2023 | 20501 | 2.380 |
Why?
|
| Antigens, Viral | 9 | 2020 | 132 | 2.210 |
Why?
|
| Mice, Transgenic | 58 | 2023 | 1271 | 2.110 |
Why?
|
| Antibody Formation | 18 | 2022 | 112 | 1.850 |
Why?
|
| Cellular Senescence | 9 | 2018 | 109 | 1.830 |
Why?
|
| Mice, Inbred BALB C | 39 | 2022 | 876 | 1.800 |
Why?
|
| Antigens | 21 | 2023 | 147 | 1.750 |
Why?
|
| Interleukin-4 | 37 | 2015 | 141 | 1.740 |
Why?
|
| Interferon-gamma | 31 | 2016 | 562 | 1.700 |
Why?
|
| Interleukin-6 | 9 | 2017 | 318 | 1.680 |
Why?
|
| Receptors, Antigen, T-Cell | 28 | 2023 | 287 | 1.650 |
Why?
|
| Mice, Inbred C57BL | 74 | 2023 | 3366 | 1.600 |
Why?
|
| Antigen-Presenting Cells | 19 | 2017 | 176 | 1.510 |
Why?
|
| B-Lymphocyte Subsets | 4 | 2020 | 46 | 1.510 |
Why?
|
| T-Lymphocytes, Cytotoxic | 11 | 2023 | 181 | 1.500 |
Why?
|
| Antibodies, Viral | 6 | 2022 | 321 | 1.380 |
Why?
|
| Th1 Cells | 19 | 2022 | 173 | 1.300 |
Why?
|
| Antigen Presentation | 11 | 2021 | 237 | 1.250 |
Why?
|
| CD8-Positive T-Lymphocytes | 19 | 2019 | 670 | 1.250 |
Why?
|
| Orthomyxoviridae | 6 | 2017 | 26 | 1.230 |
Why?
|
| Th2 Cells | 20 | 2022 | 98 | 1.160 |
Why?
|
| Homeostasis | 6 | 2013 | 369 | 1.150 |
Why?
|
| Lymphokines | 25 | 1993 | 65 | 1.110 |
Why?
|
| Cytotoxicity, Immunologic | 11 | 2019 | 148 | 1.110 |
Why?
|
| Lymphocyte Cooperation | 18 | 2012 | 30 | 1.100 |
Why?
|
| Immune System | 5 | 2013 | 129 | 1.090 |
Why?
|
| Immunity, Innate | 7 | 2012 | 790 | 1.050 |
Why?
|
| Cell Differentiation | 39 | 2017 | 1337 | 1.010 |
Why?
|
| Lung | 12 | 2020 | 938 | 1.000 |
Why?
|
| Thymus Gland | 8 | 2011 | 232 | 0.980 |
Why?
|
| Histocompatibility Antigens Class II | 13 | 2023 | 182 | 0.950 |
Why?
|
| Mice, Knockout | 30 | 2022 | 2092 | 0.940 |
Why?
|
| Apoptosis | 16 | 2016 | 1069 | 0.920 |
Why?
|
| Interleukin-7 | 3 | 2014 | 30 | 0.900 |
Why?
|
| Perforin | 4 | 2012 | 31 | 0.850 |
Why?
|
| Cells, Cultured | 39 | 2017 | 2140 | 0.850 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 4 | 2012 | 90 | 0.780 |
Why?
|
| Interleukins | 15 | 2015 | 79 | 0.770 |
Why?
|
| Murine Acquired Immunodeficiency Syndrome | 6 | 2002 | 8 | 0.750 |
Why?
|
| Cell Communication | 10 | 2014 | 130 | 0.740 |
Why?
|
| Viruses | 2 | 2013 | 81 | 0.740 |
Why?
|
| Immunity, Cellular | 11 | 2015 | 174 | 0.740 |
Why?
|
| Virus Diseases | 2 | 2013 | 117 | 0.730 |
Why?
|
| Interferon Type I | 1 | 2023 | 187 | 0.730 |
Why?
|
| Cell Proliferation | 9 | 2016 | 979 | 0.710 |
Why?
|
| Autoimmunity | 2 | 2020 | 233 | 0.640 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 2 | 2016 | 2 | 0.630 |
Why?
|
| Host-Pathogen Interactions | 2 | 2018 | 259 | 0.600 |
Why?
|
| Adoptive Transfer | 10 | 2017 | 148 | 0.590 |
Why?
|
| Immune Tolerance | 5 | 2009 | 176 | 0.590 |
Why?
|
| Humans | 59 | 2022 | 63001 | 0.590 |
Why?
|
| Respirovirus Infections | 1 | 2018 | 6 | 0.580 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 662 | 0.570 |
Why?
|
| Lymphoid Tissue | 2 | 2014 | 53 | 0.560 |
Why?
|
| Dendritic Cells | 8 | 2017 | 520 | 0.560 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2008 | 336 | 0.540 |
Why?
|
| CD4 Antigens | 8 | 2001 | 149 | 0.540 |
Why?
|
| Flow Cytometry | 15 | 2017 | 659 | 0.530 |
Why?
|
| Interleukin-17 | 4 | 2011 | 91 | 0.520 |
Why?
|
| Membrane Glycoproteins | 6 | 2016 | 664 | 0.510 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2014 | 9 | 0.460 |
Why?
|
| Respiratory Mucosa | 1 | 2014 | 53 | 0.450 |
Why?
|
| Antigens, CD | 14 | 2015 | 346 | 0.440 |
Why?
|
| Phenotype | 19 | 2012 | 1192 | 0.440 |
Why?
|
| Spleen | 16 | 2016 | 483 | 0.440 |
Why?
|
| Cell Survival | 9 | 2010 | 566 | 0.430 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2010 | 148 | 0.410 |
Why?
|
| Vaccination | 3 | 2019 | 362 | 0.410 |
Why?
|
| Toll-Like Receptors | 2 | 2017 | 429 | 0.410 |
Why?
|
| Signal Transduction | 16 | 2018 | 3014 | 0.400 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 101 | 0.400 |
Why?
|
| CD40 Ligand | 4 | 2008 | 158 | 0.390 |
Why?
|
| Respiratory Tract Infections | 1 | 2013 | 88 | 0.390 |
Why?
|
| Transforming Growth Factor beta | 5 | 1999 | 172 | 0.390 |
Why?
|
| Models, Immunological | 5 | 2017 | 85 | 0.390 |
Why?
|
| Growth Substances | 11 | 1990 | 34 | 0.380 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2010 | 324 | 0.370 |
Why?
|
| Resting Phase, Cell Cycle | 2 | 2010 | 11 | 0.370 |
Why?
|
| Immunophenotyping | 10 | 2008 | 193 | 0.360 |
Why?
|
| Interleukin-15 | 2 | 2023 | 25 | 0.350 |
Why?
|
| Periodicals as Topic | 1 | 2013 | 172 | 0.350 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 6 | 2008 | 118 | 0.340 |
Why?
|
| Fas Ligand Protein | 2 | 2009 | 42 | 0.340 |
Why?
|
| Immunization | 4 | 2005 | 124 | 0.340 |
Why?
|
| T-Lymphocytes, Regulatory | 6 | 2020 | 208 | 0.330 |
Why?
|
| Interleukin-10 | 2 | 2015 | 160 | 0.320 |
Why?
|
| Superantigens | 2 | 2000 | 10 | 0.310 |
Why?
|
| Enterotoxins | 2 | 2000 | 21 | 0.310 |
Why?
|
| Histocompatibility Antigens | 9 | 2009 | 104 | 0.310 |
Why?
|
| Immunoglobulin M | 7 | 2022 | 114 | 0.310 |
Why?
|
| Cell Movement | 3 | 2006 | 451 | 0.310 |
Why?
|
| Cell Division | 12 | 2005 | 447 | 0.300 |
Why?
|
| Lymph Nodes | 8 | 2012 | 224 | 0.300 |
Why?
|
| DNA Damage | 2 | 2009 | 279 | 0.290 |
Why?
|
| Interleukin-12 | 5 | 2006 | 126 | 0.290 |
Why?
|
| Longevity | 1 | 2009 | 113 | 0.280 |
Why?
|
| Immunoglobulin G | 7 | 2022 | 457 | 0.280 |
Why?
|
| Membrane Proteins | 2 | 2010 | 892 | 0.280 |
Why?
|
| Kinetics | 11 | 2012 | 759 | 0.270 |
Why?
|
| Lymphocytic Choriomeningitis | 3 | 2019 | 53 | 0.270 |
Why?
|
| Interleukin-5 | 14 | 2003 | 36 | 0.270 |
Why?
|
| Receptors, Lymphocyte Homing | 7 | 2008 | 15 | 0.270 |
Why?
|
| Mice, Inbred Strains | 14 | 2005 | 189 | 0.270 |
Why?
|
| Inflammation Mediators | 3 | 2019 | 176 | 0.270 |
Why?
|
| Mice, Nude | 5 | 2014 | 269 | 0.270 |
Why?
|
| Lymphocytic choriomeningitis virus | 3 | 2019 | 89 | 0.270 |
Why?
|
| Cell Line | 20 | 2008 | 2028 | 0.260 |
Why?
|
| Peptides | 5 | 2023 | 571 | 0.260 |
Why?
|
| Adjuvants, Immunologic | 6 | 2014 | 226 | 0.260 |
Why?
|
| Molecular Sequence Data | 12 | 2010 | 1980 | 0.260 |
Why?
|
| H-2 Antigens | 11 | 1999 | 66 | 0.250 |
Why?
|
| Environment | 1 | 2007 | 121 | 0.250 |
Why?
|
| Gene Expression Regulation | 8 | 2013 | 1596 | 0.250 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 3 | 2015 | 3 | 0.240 |
Why?
|
| Allergy and Immunology | 1 | 2005 | 8 | 0.240 |
Why?
|
| Major Histocompatibility Complex | 9 | 1999 | 87 | 0.240 |
Why?
|
| Retroviridae Infections | 3 | 2001 | 13 | 0.240 |
Why?
|
| Germinal Center | 2 | 2022 | 40 | 0.240 |
Why?
|
| B7-1 Antigen | 5 | 2002 | 73 | 0.230 |
Why?
|
| Cell Cycle | 6 | 2000 | 384 | 0.220 |
Why?
|
| Cell Adhesion Molecules | 4 | 2012 | 90 | 0.220 |
Why?
|
| Epitopes | 13 | 2007 | 289 | 0.220 |
Why?
|
| Tuberculosis | 4 | 2015 | 295 | 0.220 |
Why?
|
| CD28 Antigens | 4 | 2013 | 60 | 0.220 |
Why?
|
| Immunity | 2 | 2018 | 106 | 0.220 |
Why?
|
| Leukemia, Experimental | 2 | 2001 | 19 | 0.210 |
Why?
|
| Leukemia Virus, Murine | 2 | 2001 | 30 | 0.210 |
Why?
|
| Mice, Inbred DBA | 13 | 2002 | 83 | 0.210 |
Why?
|
| Antigens, Surface | 7 | 1993 | 196 | 0.210 |
Why?
|
| Immunoglobulin D | 2 | 2022 | 9 | 0.210 |
Why?
|
| Clonal Anergy | 3 | 2001 | 23 | 0.210 |
Why?
|
| Vaccines, Attenuated | 2 | 2022 | 35 | 0.210 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 8 | 2015 | 108 | 0.200 |
Why?
|
| Male | 21 | 2022 | 29706 | 0.200 |
Why?
|
| Hemagglutinins, Viral | 3 | 2009 | 12 | 0.200 |
Why?
|
| Time Factors | 12 | 2008 | 3752 | 0.200 |
Why?
|
| Granzymes | 3 | 2016 | 21 | 0.200 |
Why?
|
| Societies, Medical | 1 | 2005 | 372 | 0.200 |
Why?
|
| Vaccines, Inactivated | 1 | 2022 | 12 | 0.200 |
Why?
|
| Plasma Cells | 2 | 2017 | 53 | 0.200 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2009 | 281 | 0.190 |
Why?
|
| Transcription Factors | 5 | 2016 | 1502 | 0.190 |
Why?
|
| Immunoconjugates | 1 | 2002 | 90 | 0.190 |
Why?
|
| Amino Acid Sequence | 9 | 2010 | 1583 | 0.190 |
Why?
|
| Pathogen-Associated Molecular Pattern Molecules | 1 | 2021 | 5 | 0.190 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2022 | 103 | 0.180 |
Why?
|
| Genes, MHC Class II | 3 | 2014 | 37 | 0.180 |
Why?
|
| Female | 24 | 2022 | 32654 | 0.180 |
Why?
|
| Mycobacterium tuberculosis | 3 | 2015 | 405 | 0.180 |
Why?
|
| Bone Marrow Transplantation | 4 | 2008 | 139 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 449 | 0.180 |
Why?
|
| Interleukin-18 | 1 | 2001 | 73 | 0.180 |
Why?
|
| Cell Separation | 3 | 2010 | 147 | 0.180 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2022 | 209 | 0.180 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 3 | 2016 | 28 | 0.170 |
Why?
|
| Cytochrome c Group | 5 | 2000 | 25 | 0.170 |
Why?
|
| Receptors, Interleukin-2 | 4 | 2002 | 71 | 0.170 |
Why?
|
| omega-Chloroacetophenone | 1 | 2020 | 2 | 0.170 |
Why?
|
| Base Sequence | 7 | 2012 | 1322 | 0.170 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 7 | 2 | 2014 | 25 | 0.170 |
Why?
|
| Isoantigens | 8 | 1991 | 71 | 0.170 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2020 | 25 | 0.170 |
Why?
|
| Bcl-2-Like Protein 11 | 2 | 2010 | 19 | 0.170 |
Why?
|
| Concanavalin A | 6 | 1991 | 40 | 0.170 |
Why?
|
| Lymphocyte Subsets | 3 | 2012 | 37 | 0.170 |
Why?
|
| Myeloid Cells | 1 | 2000 | 94 | 0.160 |
Why?
|
| Cross Reactions | 3 | 2019 | 129 | 0.160 |
Why?
|
| CD11c Antigen | 1 | 2020 | 8 | 0.160 |
Why?
|
| Staphylococcus aureus | 2 | 2000 | 176 | 0.160 |
Why?
|
| Mice, SCID | 4 | 2013 | 517 | 0.160 |
Why?
|
| L-Selectin | 4 | 2007 | 14 | 0.160 |
Why?
|
| Models, Biological | 7 | 2011 | 1174 | 0.160 |
Why?
|
| Pore Forming Cytotoxic Proteins | 2 | 2012 | 34 | 0.160 |
Why?
|
| Disease Models, Animal | 4 | 2016 | 2167 | 0.160 |
Why?
|
| Immunoglobulin Isotypes | 4 | 1999 | 24 | 0.160 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 1996 | 53 | 0.160 |
Why?
|
| Thymectomy | 6 | 2009 | 33 | 0.160 |
Why?
|
| Antibodies, Monoclonal | 9 | 2020 | 860 | 0.160 |
Why?
|
| Immunoglobulins | 5 | 1995 | 77 | 0.160 |
Why?
|
| Hemocyanins | 7 | 1996 | 23 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2012 | 610 | 0.150 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2012 | 111 | 0.150 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 217 | 0.140 |
Why?
|
| Biomarkers | 3 | 2016 | 1391 | 0.140 |
Why?
|
| Signaling Lymphocytic Activation Molecule Associated Protein | 2 | 2008 | 3 | 0.140 |
Why?
|
| Viral Vaccines | 1 | 2018 | 47 | 0.140 |
Why?
|
| RNA, Messenger | 8 | 2007 | 1530 | 0.140 |
Why?
|
| Lymphocyte Depletion | 3 | 2012 | 99 | 0.140 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2017 | 92 | 0.140 |
Why?
|
| Interleukin-3 | 3 | 1991 | 20 | 0.130 |
Why?
|
| Th17 Cells | 2 | 2022 | 61 | 0.130 |
Why?
|
| Lectins, C-Type | 5 | 2015 | 89 | 0.130 |
Why?
|
| Survival Rate | 3 | 2009 | 845 | 0.130 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2016 | 8 | 0.130 |
Why?
|
| Leukocyte Common Antigens | 6 | 1996 | 59 | 0.130 |
Why?
|
| fas Receptor | 1 | 1997 | 57 | 0.130 |
Why?
|
| Peyer's Patches | 5 | 2003 | 35 | 0.130 |
Why?
|
| Genes, cdc | 1 | 2016 | 15 | 0.130 |
Why?
|
| Nitric Oxide | 2 | 2012 | 172 | 0.130 |
Why?
|
| Mice, Mutant Strains | 2 | 2008 | 300 | 0.130 |
Why?
|
| Gene Expression Profiling | 2 | 2012 | 767 | 0.130 |
Why?
|
| CD40 Antigens | 3 | 2002 | 60 | 0.130 |
Why?
|
| In Vitro Techniques | 5 | 2002 | 486 | 0.130 |
Why?
|
| Pneumonia | 1 | 2019 | 287 | 0.130 |
Why?
|
| Interleukin-21 Receptor alpha Subunit | 1 | 2015 | 2 | 0.120 |
Why?
|
| Receptors, Cytokine | 1 | 2015 | 13 | 0.120 |
Why?
|
| Interleukin-13 | 1 | 2015 | 37 | 0.120 |
Why?
|
| Receptors, Interleukin | 1 | 2015 | 38 | 0.120 |
Why?
|
| Succinimides | 2 | 2005 | 17 | 0.120 |
Why?
|
| Fluoresceins | 2 | 2005 | 30 | 0.120 |
Why?
|
| Coculture Techniques | 2 | 2010 | 96 | 0.120 |
Why?
|
| Fibrosarcoma | 1 | 2015 | 13 | 0.120 |
Why?
|
| Pulmonary Fibrosis | 1 | 2015 | 79 | 0.120 |
Why?
|
| CD27 Ligand | 1 | 2014 | 3 | 0.120 |
Why?
|
| Hyaluronan Receptors | 5 | 2004 | 35 | 0.110 |
Why?
|
| Immune Sera | 4 | 2002 | 34 | 0.110 |
Why?
|
| Autocrine Communication | 1 | 2014 | 30 | 0.110 |
Why?
|
| Macrophages | 3 | 2001 | 1033 | 0.110 |
Why?
|
| Bronchi | 1 | 2014 | 78 | 0.110 |
Why?
|
| Isoantibodies | 4 | 1984 | 35 | 0.110 |
Why?
|
| Interferon Regulatory Factors | 1 | 2014 | 43 | 0.110 |
Why?
|
| Antibody-Producing Cells | 3 | 1985 | 12 | 0.110 |
Why?
|
| Antibodies | 1 | 1994 | 182 | 0.110 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2013 | 61 | 0.100 |
Why?
|
| Antilymphocyte Serum | 5 | 1990 | 22 | 0.100 |
Why?
|
| Columbidae | 3 | 2000 | 12 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 538 | 0.100 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 125 | 0.100 |
Why?
|
| Mycobacterium avium | 1 | 2012 | 5 | 0.100 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 1 | 2012 | 5 | 0.100 |
Why?
|
| Melanoma | 1 | 2016 | 331 | 0.100 |
Why?
|
| Antigens, T-Independent | 2 | 2000 | 10 | 0.100 |
Why?
|
| Genes, Viral | 1 | 2012 | 57 | 0.100 |
Why?
|
| Ligands | 3 | 2010 | 414 | 0.100 |
Why?
|
| Chickens | 1 | 2012 | 94 | 0.100 |
Why?
|
| Dose-Response Relationship, Immunologic | 4 | 2000 | 50 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 68 | 0.100 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2011 | 6 | 0.090 |
Why?
|
| Drug Synergism | 6 | 1995 | 140 | 0.090 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2002 | 180 | 0.090 |
Why?
|
| DNA, Viral | 1 | 2012 | 231 | 0.090 |
Why?
|
| Models, Animal | 2 | 2009 | 232 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 295 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2011 | 48 | 0.090 |
Why?
|
| Aged | 2 | 2020 | 14335 | 0.090 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 2 | 2008 | 9 | 0.090 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2011 | 36 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2004 | 318 | 0.080 |
Why?
|
| Caspase 8 | 2 | 2008 | 64 | 0.080 |
Why?
|
| CD3 Complex | 3 | 1995 | 65 | 0.080 |
Why?
|
| Enzyme Activation | 2 | 2008 | 379 | 0.080 |
Why?
|
| Chemokines | 1 | 2010 | 93 | 0.080 |
Why?
|
| Guided Tissue Regeneration | 1 | 2009 | 4 | 0.080 |
Why?
|
| Recombinant Proteins | 4 | 2002 | 695 | 0.080 |
Why?
|
| Ovalbumin | 1 | 2009 | 116 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 125 | 0.070 |
Why?
|
| Geriatrics | 1 | 2009 | 43 | 0.070 |
Why?
|
| CTLA-4 Antigen | 2 | 2013 | 72 | 0.070 |
Why?
|
| Blood Group Antigens | 1 | 1988 | 7 | 0.070 |
Why?
|
| Antigens, Ly | 4 | 1983 | 42 | 0.070 |
Why?
|
| Regeneration | 1 | 2009 | 93 | 0.070 |
Why?
|
| T-Box Domain Proteins | 2 | 2022 | 38 | 0.070 |
Why?
|
| Bone Marrow Cells | 1 | 2008 | 237 | 0.070 |
Why?
|
| Caspases | 2 | 2007 | 174 | 0.070 |
Why?
|
| Mycobacterium Infections | 1 | 2007 | 16 | 0.070 |
Why?
|
| Radiation Chimera | 3 | 2008 | 58 | 0.070 |
Why?
|
| Dextrans | 5 | 1988 | 45 | 0.070 |
Why?
|
| NFATC Transcription Factors | 1 | 2007 | 20 | 0.070 |
Why?
|
| Fluorescence | 1 | 2007 | 90 | 0.070 |
Why?
|
| Interleukin-23 | 1 | 2007 | 18 | 0.070 |
Why?
|
| Lymphopenia | 1 | 2007 | 34 | 0.070 |
Why?
|
| Lymphocyte Transfusion | 1 | 2006 | 37 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2009 | 296 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2009 | 408 | 0.070 |
Why?
|
| Adaptation, Biological | 1 | 2007 | 18 | 0.070 |
Why?
|
| Peritoneum | 1 | 2006 | 30 | 0.070 |
Why?
|
| Cross-Priming | 1 | 2007 | 16 | 0.070 |
Why?
|
| Tuberculosis Vaccines | 1 | 2007 | 30 | 0.070 |
Why?
|
| Titrimetry | 1 | 2006 | 11 | 0.070 |
Why?
|
| Cold Temperature | 1 | 2007 | 50 | 0.060 |
Why?
|
| Stem Cells | 1 | 2008 | 256 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2020 | 369 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2006 | 290 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2004 | 93 | 0.060 |
Why?
|
| Immunoglobulin A | 4 | 1989 | 95 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 1143 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2006 | 166 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2008 | 468 | 0.060 |
Why?
|
| Receptors, Immunologic | 3 | 2015 | 177 | 0.060 |
Why?
|
| Transfection | 4 | 2000 | 691 | 0.060 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2016 | 58 | 0.060 |
Why?
|
| Proteome | 1 | 2006 | 147 | 0.060 |
Why?
|
| Transplantation Chimera | 1 | 2005 | 40 | 0.060 |
Why?
|
| Leukemia | 1 | 1985 | 62 | 0.060 |
Why?
|
| Mutation | 2 | 2012 | 2597 | 0.060 |
Why?
|
| Mice, Inbred C3H | 4 | 1997 | 175 | 0.060 |
Why?
|
| Immunotherapy, Adoptive | 3 | 1994 | 94 | 0.060 |
Why?
|
| Thy-1 Antigens | 2 | 2000 | 20 | 0.060 |
Why?
|
| BCG Vaccine | 1 | 2004 | 51 | 0.060 |
Why?
|
| Mycobacterium bovis | 2 | 2004 | 28 | 0.060 |
Why?
|
| Calcium | 2 | 2007 | 570 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2006 | 295 | 0.050 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2003 | 16 | 0.050 |
Why?
|
| Interphase | 2 | 2000 | 66 | 0.050 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1983 | 44 | 0.050 |
Why?
|
| Interferons | 2 | 2019 | 70 | 0.050 |
Why?
|
| Immunoglobulin Fragments | 1 | 2002 | 7 | 0.050 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2003 | 14 | 0.050 |
Why?
|
| Receptors, CCR3 | 1 | 2002 | 3 | 0.050 |
Why?
|
| Receptors, CCR7 | 1 | 2002 | 9 | 0.050 |
Why?
|
| Transcriptional Activation | 2 | 2007 | 190 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2002 | 33 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2003 | 198 | 0.050 |
Why?
|
| Age Factors | 1 | 2007 | 1549 | 0.050 |
Why?
|
| B7-2 Antigen | 1 | 2002 | 32 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 47 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 182 | 0.050 |
Why?
|
| Boron Compounds | 1 | 2002 | 20 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 1999 | 1177 | 0.050 |
Why?
|
| Antibodies, Blocking | 1 | 2002 | 39 | 0.050 |
Why?
|
| Abatacept | 1 | 2002 | 65 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2002 | 138 | 0.050 |
Why?
|
| Mice, Inbred CBA | 4 | 1983 | 82 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 399 | 0.050 |
Why?
|
| Proteins | 3 | 2005 | 747 | 0.050 |
Why?
|
| Lymphocyte Count | 1 | 2002 | 72 | 0.050 |
Why?
|
| Trichuriasis | 1 | 2001 | 1 | 0.050 |
Why?
|
| Hypergammaglobulinemia | 1 | 2001 | 2 | 0.050 |
Why?
|
| Listeriosis | 1 | 2001 | 30 | 0.050 |
Why?
|
| Lymphatic Diseases | 1 | 2001 | 13 | 0.040 |
Why?
|
| Splenomegaly | 1 | 2001 | 24 | 0.040 |
Why?
|
| Autoantigens | 1 | 2002 | 137 | 0.040 |
Why?
|
| Inflammation | 2 | 2020 | 1141 | 0.040 |
Why?
|
| Endocytosis | 2 | 2000 | 152 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2000 | 20 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1991 | 149 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 198 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2000 | 154 | 0.040 |
Why?
|
| Monocytes | 1 | 1982 | 353 | 0.040 |
Why?
|
| Communicable Diseases | 1 | 2001 | 89 | 0.040 |
Why?
|
| DNA | 3 | 1996 | 829 | 0.040 |
Why?
|
| Receptors, Cell Surface | 2 | 2000 | 427 | 0.040 |
Why?
|
| Colony-Stimulating Factors | 2 | 1990 | 5 | 0.040 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2000 | 7 | 0.040 |
Why?
|
| Plasmids | 2 | 2002 | 289 | 0.040 |
Why?
|
| Receptors, Natural Killer Cell | 1 | 2019 | 2 | 0.040 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1990 | 73 | 0.040 |
Why?
|
| Immunoglobulin Switch Region | 1 | 1999 | 21 | 0.040 |
Why?
|
| Lysosomes | 1 | 2000 | 167 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2001 | 577 | 0.040 |
Why?
|
| Carrier Proteins | 3 | 2005 | 702 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2000 | 223 | 0.040 |
Why?
|
| Dextran Sulfate | 3 | 1988 | 40 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 1999 | 515 | 0.040 |
Why?
|
| Sheep | 4 | 1988 | 175 | 0.040 |
Why?
|
| Antibodies, Anti-Idiotypic | 4 | 1988 | 33 | 0.040 |
Why?
|
| Leukocyte Count | 2 | 1989 | 97 | 0.040 |
Why?
|
| Protein Biosynthesis | 3 | 1990 | 316 | 0.040 |
Why?
|
| Binding, Competitive | 3 | 1984 | 99 | 0.040 |
Why?
|
| Hemolytic Plaque Technique | 4 | 1985 | 11 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 1999 | 279 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 4 | 1989 | 230 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 1 | 1997 | 1 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1990 | 65 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1997 | 59 | 0.030 |
Why?
|
| Hybridomas | 2 | 1991 | 62 | 0.030 |
Why?
|
| Mice, Inbred A | 3 | 1983 | 20 | 0.030 |
Why?
|
| Genes | 1 | 1977 | 89 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1997 | 216 | 0.030 |
Why?
|
| Genes, bcl-2 | 1 | 1996 | 9 | 0.030 |
Why?
|
| Disease Progression | 1 | 2001 | 1161 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 1977 | 288 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 1996 | 41 | 0.030 |
Why?
|
| Tumor Virus Infections | 1 | 1996 | 36 | 0.030 |
Why?
|
| Gene Expression | 2 | 2007 | 831 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2008 | 606 | 0.030 |
Why?
|
| Caspase 3 | 2 | 2008 | 108 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 1996 | 80 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 1998 | 347 | 0.030 |
Why?
|
| Bleomycin | 1 | 2015 | 34 | 0.030 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 1995 | 12 | 0.030 |
Why?
|
| Immune Evasion | 1 | 2016 | 68 | 0.030 |
Why?
|
| Clone Cells | 4 | 1986 | 114 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2015 | 1 | 0.030 |
Why?
|
| Cytotoxicity Tests, Immunologic | 2 | 2012 | 30 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 241 | 0.030 |
Why?
|
| Tumor Escape | 1 | 2015 | 16 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 164 | 0.030 |
Why?
|
| Cell Death | 1 | 1996 | 284 | 0.030 |
Why?
|
| Transcriptome | 1 | 2017 | 387 | 0.030 |
Why?
|
| Mitomycins | 3 | 1979 | 6 | 0.030 |
Why?
|
| Mesentery | 1 | 1993 | 15 | 0.030 |
Why?
|
| Rats | 2 | 1994 | 1963 | 0.030 |
Why?
|
| Cricetulus | 1 | 2013 | 98 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2015 | 312 | 0.030 |
Why?
|
| CHO Cells | 1 | 2013 | 186 | 0.030 |
Why?
|
| Neoplasms, Experimental | 2 | 1984 | 77 | 0.030 |
Why?
|
| Cricetinae | 1 | 2013 | 364 | 0.030 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2012 | 22 | 0.030 |
Why?
|
| Granuloma, Respiratory Tract | 1 | 2012 | 2 | 0.020 |
Why?
|
| United States | 1 | 2005 | 7782 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 524 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1984 | 204 | 0.020 |
Why?
|
| Acute Disease | 1 | 2014 | 669 | 0.020 |
Why?
|
| Species Specificity | 2 | 1983 | 334 | 0.020 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 1992 | 59 | 0.020 |
Why?
|
| Antigens, Bacterial | 2 | 2007 | 198 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2011 | 31 | 0.020 |
Why?
|
| Glutaral | 1 | 1991 | 3 | 0.020 |
Why?
|
| Fixatives | 1 | 1991 | 16 | 0.020 |
Why?
|
| Interleukin-1 | 2 | 1982 | 156 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 1988 | 60 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 1983 | 34 | 0.020 |
Why?
|
| Lymphoma | 2 | 1988 | 102 | 0.020 |
Why?
|
| Polyribosomes | 1 | 1990 | 15 | 0.020 |
Why?
|
| Lipopolysaccharides | 3 | 1988 | 620 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1990 | 110 | 0.020 |
Why?
|
| Rabbits | 1 | 1990 | 329 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2007 | 873 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1990 | 101 | 0.020 |
Why?
|
| Cell Adhesion | 2 | 2000 | 205 | 0.020 |
Why?
|
| Cattle | 1 | 1990 | 306 | 0.020 |
Why?
|
| Antibodies, Bacterial | 2 | 1996 | 181 | 0.020 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1989 | 23 | 0.020 |
Why?
|
| Microtubules | 2 | 1987 | 209 | 0.020 |
Why?
|
| Cell-Free System | 1 | 1988 | 31 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2008 | 22 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 1988 | 31 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2008 | 78 | 0.020 |
Why?
|
| Ribosomes | 1 | 1990 | 163 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 47 | 0.020 |
Why?
|
| Trinitrobenzenes | 2 | 1978 | 7 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 65 | 0.020 |
Why?
|
| Vaccines | 1 | 2009 | 96 | 0.020 |
Why?
|
| Immunologic Capping | 1 | 1987 | 10 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 179 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2007 | 30 | 0.020 |
Why?
|
| Nucleoproteins | 1 | 2007 | 34 | 0.020 |
Why?
|
| Nucleocapsid Proteins | 1 | 2007 | 34 | 0.020 |
Why?
|
| Viral Core Proteins | 1 | 2007 | 31 | 0.020 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2006 | 17 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 2006 | 29 | 0.020 |
Why?
|
| Mitosis | 1 | 1988 | 215 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 2007 | 115 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 1987 | 199 | 0.020 |
Why?
|
| Pneumonia, Viral | 1 | 2009 | 222 | 0.020 |
Why?
|
| Phylogeny | 1 | 2007 | 376 | 0.010 |
Why?
|
| Education, Professional | 1 | 2005 | 10 | 0.010 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2005 | 9 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 886 | 0.010 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2005 | 81 | 0.010 |
Why?
|
| Isoelectric Focusing | 1 | 1984 | 9 | 0.010 |
Why?
|
| Proteomics | 1 | 2006 | 280 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1984 | 25 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1987 | 492 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1984 | 65 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2005 | 334 | 0.010 |
Why?
|
| Protein Conformation | 2 | 1987 | 778 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 431 | 0.010 |
Why?
|
| Sendai virus | 1 | 2002 | 11 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2002 | 41 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2003 | 33 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1982 | 72 | 0.010 |
Why?
|
| Mice, Inbred AKR | 1 | 1982 | 12 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 451 | 0.010 |
Why?
|
| Genetics | 1 | 1981 | 13 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 760 | 0.010 |
Why?
|
| Nematospiroides dubius | 1 | 2000 | 4 | 0.010 |
Why?
|
| Strongylida Infections | 1 | 2000 | 5 | 0.010 |
Why?
|
| Toxoplasmosis, Animal | 1 | 2000 | 10 | 0.010 |
Why?
|
| Erythrocytes | 2 | 1979 | 149 | 0.010 |
Why?
|
| Culture Media | 1 | 1981 | 79 | 0.010 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2000 | 35 | 0.010 |
Why?
|
| Adsorption | 1 | 2000 | 83 | 0.010 |
Why?
|
| Immunomagnetic Separation | 1 | 2000 | 9 | 0.010 |
Why?
|
| Receptors, IgG | 1 | 2000 | 41 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2000 | 45 | 0.010 |
Why?
|
| Macrophage-1 Antigen | 1 | 2000 | 29 | 0.010 |
Why?
|
| Homozygote | 1 | 1980 | 123 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 1980 | 83 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1982 | 377 | 0.010 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 1999 | 5 | 0.010 |
Why?
|
| TCF Transcription Factors | 1 | 1999 | 6 | 0.010 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 1999 | 5 | 0.010 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 1999 | 11 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2000 | 300 | 0.010 |
Why?
|
| Endosomes | 1 | 2000 | 178 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 488 | 0.010 |
Why?
|
| Dinitrobenzenes | 1 | 1978 | 6 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2002 | 493 | 0.010 |
Why?
|
| Hemagglutinins | 1 | 1998 | 17 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1999 | 245 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 16722 | 0.010 |
Why?
|
| Haploidy | 1 | 1977 | 10 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 1998 | 102 | 0.010 |
Why?
|
| Histocompatibility | 1 | 1977 | 7 | 0.010 |
Why?
|
| Transgenes | 1 | 1998 | 187 | 0.010 |
Why?
|
| Galactosidases | 1 | 1977 | 2 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1998 | 143 | 0.010 |
Why?
|
| Diffusion Chambers, Culture | 1 | 1996 | 1 | 0.010 |
Why?
|
| Mollusca | 1 | 1996 | 10 | 0.010 |
Why?
|
| Lac Operon | 1 | 1996 | 26 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1996 | 69 | 0.010 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1996 | 13 | 0.010 |
Why?
|
| Immunization, Secondary | 1 | 1996 | 45 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1996 | 77 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1999 | 620 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 1996 | 64 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 1996 | 91 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1996 | 254 | 0.010 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1992 | 19 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1992 | 103 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1996 | 694 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1992 | 203 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1996 | 868 | 0.010 |
Why?
|
| Genes, MHC Class I | 1 | 1989 | 27 | 0.000 |
Why?
|
| Cloning, Molecular | 1 | 1989 | 375 | 0.000 |
Why?
|
| Talin | 1 | 1987 | 3 | 0.000 |
Why?
|
| Biological Assay | 1 | 1987 | 58 | 0.000 |
Why?
|
| Chloroquine | 1 | 1987 | 61 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1987 | 228 | 0.000 |
Why?
|
| Antigens, Neoplasm | 1 | 1987 | 133 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1987 | 386 | 0.000 |
Why?
|
| Cell Count | 1 | 1982 | 130 | 0.000 |
Why?
|
| Sepharose | 1 | 1981 | 7 | 0.000 |
Why?
|
| Animals, Newborn | 1 | 1981 | 234 | 0.000 |
Why?
|
| RNA | 1 | 1984 | 423 | 0.000 |
Why?
|